China Money Network’s DealShot provides detailed information on venture capital and private equity deals in China on a daily basis.
Here you can find out where Chinese investors have been investing their money in at around 5pm each workday.
|Company||Round||Amount||Lead Investor||Participants||Company Intro|
|3D Medicines||Series E||US$101 million||China Reform Holdings Co., Ltd.||ChinaEquity Group||3D Medicines is a Shanghai-based healthcare company developing precision medicine for cancer treatment. The company has a complete product line for cancer detection, including histology genomic test, ctDNA liquid biopsy and exosome liquid biopsy, which has been applied in over 300 hospitals in China.|
|Energy Monster||Series B||US$30 million||Shunwei Capital, Bluerun Ventures, Sky9 Capital, Hillhouse Capital, Crystal Stream Capital, Xiaomi Inc., Zimi Technology, GF Xinde Investment Management||Energy Monster is a Chinese portable power bank rental company, allowing users to rent power banks by scanning QR code.|
|Uhouzz||Series B||US$14 million||TransLink Capital||New Oriental Education & Technology Group Inc.||Uhouzz is a Chinese online platform for international students to rent apartments in U.S., U.K., Australia, Canada, New Zealand, Japan and Singapore.|
|Preceptis Medical||Series B||undisclosed||undisclosed||Preceptis Medical Inc. is a U.S.-based pediatric surgical technologies developer. The company develops Hummingbird Tympanostomy Tube System technology that enables a conscious sedation alternative to general anesthesia for placing ear tubes in children.|
|XmanData||Pre-A||US$3 million||Chunxiao Capital||Tsing Ventures||XmanData is a Shanghai-based data analysis company. It collects and analyzes data on commercial areas, including the main customers and trends in the area for micro and small enterprises.|